Peer-Reviewed Journal Details
Mandatory Fields
Hortiguela, MJ,Wall, JG
2013
March
Marine Drugs
Improved Detection of Domoic Acid Using Covalently Immobilised Antibody Fragments
Published
()
Optional Fields
domoic acid scFv antibody fragment covalent immobilisation protein engineering cysteine ESCHERICHIA-COLI CYTOPLASM PROTEIN-PRODUCTION MARINE TOXINS IN-VITRO EXPRESSION DSBC OPTIMIZATION TASSER SCFV
11
881
895
Antibody molecules, and antibody fragments in particular, have enormous potential in the development of biosensors for marine monitoring. Conventional immobilisation approaches used in immunoassays typically yield unstable and mostly incorrectly oriented antibodies, however, resulting in reduced detection sensitivities for already low concentration analytes. The 2H12 anti-domoic acid scFv antibody fragment was engineered with cysteine-containing linkers of two different lengths, distal to the antigen binding pocket, for covalent and correctly oriented immobilisation of the scFvs on functionalised solid supports. The Escherichia coli-produced, cysteine-engineered scFvs dimerised in solution and demonstrated similar efficiencies of covalent immobilisation on maleimide-activated plates and minimal non-covalent attachment. The covalently attached scFvs exhibited negligible leaching from the support under acidic conditions that removed almost 50% of the adsorbed wildtype fragment, and IC(50)s for domoic acid of 270 and 297 ng/mL compared with 1126 and 1482 ng/mL, respectively, for their non-covalently adsorbed counterparts. The expression and immobilisation approach will facilitate the development of stable, reusable biosensors with increased stability and detection sensitivity for marine neurotoxins.
10.3390/md11030881
Grant Details
Publication Themes